Why Akebia Therapeutics Stock Is Jumping Today
Momentum is continuing for the biotech after an announcement of positive clinical results and buying by key insiders earlier this month.
Akebia Therapeutics
AKBA
AKBA
$7.93
-$0.64
-7.5%
BATS BZX Real Time Price as of January 24, 2020, 4:30 p.m. EST
View Interactive AKBA Charts
AKEBIA THERAPEUTICS INC COM USD0.00001
News & Analysis: Akebia Therapeutics
Why Akebia Therapeutics Stock Is Jumping Today
Insider buying is generating enthusiasm for this biotech stock among investors who aren't insiders.
$100 Million Loan Overshadows Akebia Therapeutics' Q3 Earnings Miss
The biotech's Q3 results weren't anything to crow about. But a big loan agreement will allow Akebia to fund operations until key clinical results are announced.
Akebia Therapeutics Inc (AKBA) Q3 2019 Earnings Call Transcript
AKBA earnings call for the period ending September 30, 2019.
Akebia Therapeutics, Inc. (AKBA) Q2 2019 Earnings Call Transcript
AKBA earnings call for the period ending June 30, 2019.
Akebia Therapeutics, Inc. (AKBA) Q1 2019 Earnings Call Transcript
AKBA earnings call for the period ending March 31, 2019.
Akebia Therapeutics (AKBA) Q4 2018 Earnings Conference Call Transcript
AKBA earnings call for the period ending December 31, 2018.
Why Akebia Therapeutics, Momo, and Switch Jumped Today
Good news on several fronts helped lift many stocks.
Why Akebia Therapeutics Is Soaring Today
Great news from two late-stage studies lit a fire under the biopharmaceutical stock.
Why Akebia Therapeutics Is Soaring Today
Traders cheer after the company completes its merger agreement. Here's what investors need to know.
